Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

BACKGROUND: HBeAg-negative chronic hepatitis B patients require long-term nucleos(t)ide analogues(NAs) because loss of surface antigen (HBsAg) is unusual. Low quantitative HBsAg (qHBsAg) levels can identify patients with higher probability of seroclearance. The aim of our study was to evaluate qHBsA...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Broquetas, Teresa, Garcia-Retortillo, Montserrat, Hernandez, Juan José, Puigvehí, Marc, Cañete, Nuria, Coll, Susana, Cabrero, Beatriz, Giménez, Maria Dolors, Solà, Ricard, Carrión, José A.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5708657/
https://ncbi.nlm.nih.gov/pubmed/29190670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188303
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items